Similar articles for PMID: 2911037

Year	Number of Results
1967	2
1968	1
1971	1
1979	1
1987	1
1988	7
1989	3
1990	1
1993	1
1999	1
2003	2
2004	1
2005	1
2006	1
2007	2
2008	2
2009	1
2011	1
2012	1
2017	1
2020	1
2024	0

1

Assessment of the purity of d,l HM-PAO from diastereomeric mixtures using NMR techniques.

Feinstein-Jaffe I, Boazi M, Tor Y. Feinstein-Jaffe I, et al. J Nucl Med. 1989 Jan;30(1):106-9. J Nucl Med. 1989. PMID: 2911037 Free article.

2

[NMR identification and stereoisomeric purity determination of HM-PAO diastereoisomers].

Wen JQ, Wang JZ, Shao LR. Wen JQ, et al. Yao Xue Xue Bao. 1989;24(10):733-6. Yao Xue Xue Bao. 1989. PMID: 2618663 Chinese.

3

Technetium-99m HM-PAO stereoisomers: differences in interaction with glutathione.

Ballinger JR, Reid RH, Gulenchyn KY. Ballinger JR, et al. J Nucl Med. 1988 Dec;29(12):1998-2000. J Nucl Med. 1988. PMID: 3193211 Free article.

4

Assessment of the arterial input curve for [99mTc]-d,l-HM-PAO by rapid octanol extraction.

Andersen AR, Friberg H, Lassen NA, Kristensen K, Neirinckx RD. Andersen AR, et al. J Cereb Blood Flow Metab. 1988 Dec;8(6):S23-30. doi: 10.1038/jcbfm.1988.29. J Cereb Blood Flow Metab. 1988. PMID: 3192639

5

Kinetic analysis of technetium-99m d,1-HM-PAO decomposition in aqueous media.

Hung JC, Corlija M, Volkert WA, Holmes RA. Hung JC, et al. J Nucl Med. 1988 Sep;29(9):1568-76. J Nucl Med. 1988. PMID: 3411374 Free article.

6

Determination of the diastereoisomeric purity of D,L- and meso-HM-PAO by 13C-NMR spectroscopy.

Kurteva V, Simova S. Kurteva V, et al. Eur J Med Chem. 2003 Feb;38(2):219-22. doi: 10.1016/s0223-5234(02)00008-9. Eur J Med Chem. 2003. PMID: 12620666

7

Chiral ligand-exchange chromatography as the screening method for proposed modifications in exametazime synthesis to enhance diastereoselectivity.

Nikolić N, Veselinović D, Vladimirov S, Karljiković-Rajić K, Lingeman H. Nikolić N, et al. J Pharm Biomed Anal. 2004 Feb 4;34(2):285-93. doi: 10.1016/S0731-7085(03)00551-X. J Pharm Biomed Anal. 2004. PMID: 15013142

8

New synthesis route of active substance d,l-HMPAO for preparation Technetium Tc99m Exametazime.

Pijarowska-Kruszyna J, Karczmarczyk U, Jaroń AW, Laszuk E, Radzik M, Garnuszek P, Mikołajczak R. Pijarowska-Kruszyna J, et al. Nucl Med Rev Cent East Eur. 2017;20(2):88-94. doi: 10.5603/NMR.2017.0014. Nucl Med Rev Cent East Eur. 2017. PMID: 28555448 Free article.

9

Radiochemical purity of [99mTc]HM-PAO.

Ballinger JR, Reid RH, Gulenchyn KY. Ballinger JR, et al. J Nucl Med. 1988 Apr;29(4):572-3. J Nucl Med. 1988. PMID: 3258369 Free article. No abstract available.

10

The retention mechanism of technetium-99m-HM-PAO: intracellular reaction with glutathione.

Neirinckx RD, Burke JF, Harrison RC, Forster AM, Andersen AR, Lassen NA. Neirinckx RD, et al. J Cereb Blood Flow Metab. 1988 Dec;8(6):S4-12. doi: 10.1038/jcbfm.1988.27. J Cereb Blood Flow Metab. 1988. PMID: 3192641

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

32 results

Results by year